PublicationsDiatech Admin2018-12-12T10:54:12+01:00

Publications

Leader in the development, production and
commercialisation of pharmacogenetics tests
for cancer precision medicine.

412, 2017

G Aggarwal et. al, SOX2 Immunoexpression in High-Grade Gliomas: Potential Marker for Targeted Therapy

2111, 2017

Giovanna De Meglio et al., A32 How can molecular heterogeneity impact on treatment choice in advanced colorectal cancer?

2111, 2017

Roberta Minari et. al, Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy

611, 2017

Emanuela Romagnoli et. al, A25 Management of folinic acid administration in patients with metastatic colo-rectal cancer

611, 2017

Elena Ongaro et al., A24Mutational status and metastatic patteRn in a cohort Of ADvanced colorectal cancer patients: the ROAD study

1810, 2017

Esther Diana Rossi et al.,Noninvasive follicular thyroid neoplasm with papillary-like nuclear features in the pediatric age group

1010, 2017

Elisabetta Tozzi et. al, The Headaches and Polymorphisms of the Methylenetetrahydrofolate Reductase

1809, 2017

Graziella Pinotti et al.,1335PEGFR T790M detection in TKI-naïve NSCLCs carrying sensitive EGFR mutations

1809, 2017

Elena Ongaro et al., 552PMutational status and metastatic patteRn in a cohort Of ADvanced colorectal cancer (aCRC) patients (pts): The ROAD study

809, 2017

Rossella Bruno et al., Squamous cell transformation and EGFR T790M mutation as acquired resistance mechanisms in a patient with lung adenocarcinoma treated with a tyrosine kinase inhibitor: A case report. Oncology Letters

2508, 2017

Deans ZC et al., Review of the implementation of plasma ctDNA testing on behalf of IQN Path ASBL: a perspective from an EQA providers’ survey.

2408, 2017

Annamaria Ruzzo et al., Dihydropyrimidine dehydrogenase pharmaco- genetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients. British Journal of Cancer

Previous 192021 Next